Capital One National Association’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$541K Buy
+18,686
New +$517K 0.07% 203
2016
Q4
Sell
-10,474
Closed -$218K 517
2016
Q3
$218K Sell
10,474
-2,746
-21% -$68.1K 0.02% 468
2016
Q2
$355K Sell
13,220
-3,316
-20% -$90.9K 0.03% 387
2016
Q1
$448K Sell
16,536
-3,486
-17% -$93.4K 0.04% 353
2015
Q4
$581K Sell
20,022
-1,976
-9% -$54.7K 0.05% 315
2015
Q3
$597K Buy
21,998
+222
+1% +$6.29K 0.06% 300
2015
Q2
$596K Buy
21,776
+3,728
+21% +$105K 0.05% 324
2015
Q1
$482K Sell
18,048
-4,028
-18% -$92.8K 0.04% 370
2014
Q4
$467K Buy
22,076
+5,956
+37% +$133K 0.04% 336
2014
Q3
$384K Sell
16,120
-4,512
-22% -$104K 0.04% 355
2014
Q2
$476K Sell
20,632
-6,768
-25% -$149K 0.04% 333
2014
Q1
$625K Sell
27,400
-2,760
-9% -$58.8K 0.06% 303
2013
Q4
$557K Buy
30,160
+930
+3% +$16.2K 0.05% 301
2013
Q3
$495K Buy
29,230
+840
+3% +$14.1K 0.05% 315
2013
Q2
$440K Buy
+28,390
New +$473K 0.05% 311

Other funds holding NVO

Capital One National Association's NVO Position: Q4 2019 in Review

Capital One National Association opened a new position in Novo Nordisk (NVO) in Q4 2019: 18,686 shares worth $541K. The stake represents 0.07% of the portfolio and ranks #203 among its holdings. This is a return to the name: Capital One National Association previously reported a position in NVO as recently as Q3 2016.

Capital One National Association first reported a position in NVO in Q2 2013 and has held it in 15 quarters since. The position peaked at $625K in Q1 2014. 640 funds tracked by Wall St. Rank hold NVO as of Q4 2019.

  • Capital One National Association held 18,686 shares of Novo Nordisk worth $541K as of Q4 2019.
  • Novo Nordisk was a new Capital One National Association position in Q4 2019.
  • Novo Nordisk made up 0.07% of Capital One National Association's portfolio in Q4 2019, its #203 holding.
  • Capital One National Association first reported a position in Novo Nordisk in Q2 2013 and has held it in 15 quarters since.
  • Capital One National Association's Novo Nordisk position peaked at $625K in Q1 2014.
  • 640 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2019.

Based on Capital One National Association's 13F filing for Q4 2019, filed 11 Feb 2020.